NCT02695563View on ClinicalTrials.gov

Effects of Vaginal Lactoferrin Administration Prior to Genetic Amniocentesis on Inflammatory Mediators

PHASE2CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

September 30, 2015

Conditions
Pregnancy
Interventions
DRUG

Lactoferrin

Trial Locations (1)

44124

Obstetric Unit, University of Ferrara, Cona

All Listed Sponsors
lead

Università degli Studi di Ferrara

OTHER

NCT02695563 - Effects of Vaginal Lactoferrin Administration Prior to Genetic Amniocentesis on Inflammatory Mediators | Biotech Hunter | Biotech Hunter